We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
STFYAYB provides information about the screening tests offered during and after pregnancy.
This short animation shows the screening tests offered during pregnancy…
This short animation explains why screening for infectious diseases in…
This short animation explains screening for sickle cell and thalassaemia…
This short animation explains screening for Down’s syndrome, Edwards’…
This short video explains screening for 11 physical conditions in…
Diabetic eye screening is recommended by the NHS. 1. Purpose of screening…
This short video explains screening for eyes, heart, hips and testicles in…
This short video explains screening for hearing loss in newborn babies.…
Blood spot screening is recommended by the NHS. 1. Purpose of screening…
These 8 easy read guides explain the screening tests offered during and after pregnancy for people with learning disabilities.
The processes for managing safety incidents in the NHS screening programmes.
The Patient Safety Incident Response Framework will replace the Serious…
A Adverse event An event or omission arising during clinical care and…
Guidance for local NHS screening services on how to order printed population screening leaflets.
Policy and standards for antenatal laboratories working with the NHS sickle cell and thalassaemia (SCT) screening programme.
Information for pregnant women who are offered a chorionic villus sampling (CVS) or amniocentesis diagnostic test.
Information on the programme, including the screening tests, commissioning, quality assurance, education and training.
Antenatal maternity services annual standards return 2025 to 2026
Guidance for healthcare professionals covering the pathway for sickle cell and thalassaemia screening.
Information for pregnant women to understand what it means to be a beta thalassaemia carrier.
Resources to support screening professionals in their initial training and continuing professional development (CPD).
How to support patients in accessing population screening programmes and obtaining screening results.
Sickle cell and thalassaemia high/low prevalence laboratory return 2025 to 2026
Screening standards for the sickle cell and thalassaemia (SCT) antenatal and newborn screening programme.
Leaflet for expectant fathers explaining antenatal screening for sickle cell and thalassaemia.
Information for pregnant women to understand what it means to be a sickle cell carrier.
Information for parents of babies who carry a gene for unusual haemoglobin.
Training and continuing professional development for people working in the sickle cell and thalassaemia screening programme in England.
Information for parents of babies who carry the sickle cell gene.
Guidance to support the health system to reduce inequalities in screening.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).